Vaccination Against Helicobacter Pylori in Humans
Author Information
Author(s): Aebischer T, Bumann D, Epple H J, Metzger W, Schneider T, Cherepnev G, Walduck A K, Kunkel D, Moos V, Loddenkemper C, Jiadze I, Panasyuk M, Stolte M, Graham D Y, Zeitz M, Meyer T F
Primary Institution: Max Planck Institute for Infection Biology, Berlin, Germany
Hypothesis
Can vaccination with Ty21a-based Salmonella vaccines induce protective immunity against Helicobacter pylori in humans?
Conclusion
The study found that while the vaccines did not provide satisfactory protection, some volunteers showed evidence of T cell-mediated immunity and reduced H pylori burden.
Supporting Evidence
- 13 of 58 volunteers cleared H pylori or reduced its burden after vaccination.
- T cell responses were detected in 69% of volunteers who cleared H pylori.
- Vaccines were well tolerated with only mild adverse effects reported.
Takeaway
The study tested a vaccine to see if it could help people fight off a stomach bug called Helicobacter pylori, and while it didn't work perfectly, some people did show signs of their body fighting the bug better.
Methodology
Two prospective, randomised, double-blind, controlled studies were conducted where volunteers were vaccinated with Salmonella Ty21a and then challenged with H pylori.
Limitations
The vaccines did not show satisfactory protection, and the study only observed volunteers for three months post-infection.
Participant Demographics
Volunteers were healthy males aged 20-50 years, seronegative for H pylori.
Statistical Information
P-Value
0.0002
Statistical Significance
p=0.0002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website